CD68 and cancer: The multiple immunofluorescence results showed that cancer cells with a high expression of ATG7 did not have elevated expression of PD-L1, while CD68(+) myeloid cells had strong coexpression of ATG7 and PD-L (Figures 7(a)–7(b)).